Kyle Keese Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Kyle Keese.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Kyle Keese. Kyle Keese is SVP, Corp Affairs in Emergent BioSolutions Inc. ($EBS) and SVP, Corporate Affairs in Emergent BioSolutions Inc. ($EBS) and SVP, Manufacturing in Emergent BioSolutions Inc. ($EBS) and SVP, Manufacturing Ops in Emergent BioSolutions Inc. ($EBS) and SVP, Mfg Operations in Emergent BioSolutions Inc. ($EBS) and SVP, Mfg Ops in Emergent BioSolutions Inc. ($EBS).
Latest Insider Trading Transactions of Kyle Keese
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 28 2009 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Mfg Operations | Sell | S | 0.00 | 5,000 | 0 | 336 | 5.3 K to 336 (-93.70 %) |
Sep 28 2009 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Mfg Operations | Buy | J | 0.00 | 5,040 | 0 | 5,336 | 296 to 5.3 K (+1,702.70 %) |
Mar 12 2009 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Mfg Ops | Option Exercise | A | 18.90 | 24,400 | 461,160 | 24,400 | |
Nov 12 2008 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Manufacturing ... | Sell | S | 20.34 | 100 | 2,034 | 196 | 296 to 196 (-33.78 %) |
Nov 12 2008 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Manufacturing ... | Sell | S | 20.33 | 900 | 18,297 | 296 | 1.2 K to 296 (-75.25 %) |
Nov 12 2008 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Manufacturing ... | Sell | S | 20.31 | 300 | 6,093 | 1,196 | 1.5 K to 1.2 K (-20.05 %) |
Nov 12 2008 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Manufacturing ... | Sell | S | 20.30 | 100 | 2,030 | 1,496 | 1.6 K to 1.5 K (-6.27 %) |
Nov 12 2008 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Manufacturing ... | Sell | S | 20.29 | 600 | 12,174 | 1,596 | 2.2 K to 1.6 K (-27.32 %) |
Nov 12 2008 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Manufacturing ... | Sell | S | 20.28 | 100 | 2,028 | 2,196 | 2.3 K to 2.2 K (-4.36 %) |
Nov 12 2008 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Manufacturing ... | Sell | S | 20.27 | 400 | 8,108 | 2,296 | 2.7 K to 2.3 K (-14.84 %) |
Nov 12 2008 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Manufacturing ... | Sell | S | 20.26 | 100 | 2,026 | 2,696 | 2.8 K to 2.7 K (-3.58 %) |
Nov 12 2008 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Manufacturing ... | Sell | S | 20.24 | 100 | 2,024 | 2,796 | 2.9 K to 2.8 K (-3.45 %) |
Nov 12 2008 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Manufacturing ... | Sell | S | 20.23 | 600 | 12,138 | 2,896 | 3.5 K to 2.9 K (-17.16 %) |
Nov 12 2008 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Manufacturing ... | Sell | S | 20.22 | 300 | 6,066 | 3,496 | 3.8 K to 3.5 K (-7.90 %) |
Nov 12 2008 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Manufacturing ... | Sell | S | 20.21 | 400 | 8,084 | 3,796 | 4.2 K to 3.8 K (-9.53 %) |
Nov 12 2008 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Manufacturing ... | Sell | S | 20.19 | 100 | 2,019 | 4,196 | 4.3 K to 4.2 K (-2.33 %) |
Nov 12 2008 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Manufacturing ... | Sell | S | 20.18 | 100 | 2,018 | 4,296 | 4.4 K to 4.3 K (-2.27 %) |
Nov 12 2008 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Manufacturing ... | Sell | S | 20.14 | 500 | 10,070 | 4,396 | 4.9 K to 4.4 K (-10.21 %) |
Nov 12 2008 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Manufacturing ... | Sell | S | 20.12 | 400 | 8,048 | 4,896 | 5.3 K to 4.9 K (-7.55 %) |
Nov 12 2008 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Manufacturing ... | Sell | S | 20.10 | 200 | 4,020 | 5,296 | 5.5 K to 5.3 K (-3.64 %) |
Nov 12 2008 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Manufacturing ... | Sell | S | 20.09 | 200 | 4,018 | 5,496 | 5.7 K to 5.5 K (-3.51 %) |
Nov 12 2008 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Manufacturing ... | Sell | S | 20.08 | 250 | 5,020 | 5,696 | 5.9 K to 5.7 K (-4.20 %) |
Nov 12 2008 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Manufacturing ... | Sell | S | 20.05 | 500 | 10,025 | 5,946 | 6.4 K to 5.9 K (-7.76 %) |
Nov 12 2008 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Manufacturing ... | Sell | S | 20.04 | 200 | 4,008 | 6,446 | 6.6 K to 6.4 K (-3.01 %) |
Nov 12 2008 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Manufacturing ... | Sell | S | 20.03 | 400 | 8,012 | 6,646 | 7 K to 6.6 K (-5.68 %) |
Nov 12 2008 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Manufacturing ... | Sell | S | 20.02 | 250 | 5,005 | 7,046 | 7.3 K to 7 K (-3.43 %) |
Nov 12 2008 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Manufacturing ... | Sell | S | 20.01 | 300 | 6,003 | 7,296 | 7.6 K to 7.3 K (-3.95 %) |
Nov 12 2008 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Manufacturing ... | Sell | S | 19.95 | 700 | 13,965 | 7,596 | 8.3 K to 7.6 K (-8.44 %) |
Nov 12 2008 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Manufacturing ... | Sell | S | 19.93 | 400 | 7,972 | 8,296 | 8.7 K to 8.3 K (-4.60 %) |
Nov 12 2008 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Manufacturing ... | Sell | S | 19.92 | 100 | 1,992 | 8,696 | 8.8 K to 8.7 K (-1.14 %) |
Nov 12 2008 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Manufacturing ... | Sell | S | 19.90 | 100 | 1,990 | 8,796 | 8.9 K to 8.8 K (-1.12 %) |
Nov 12 2008 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Manufacturing ... | Sell | S | 19.88 | 1,000 | 19,880 | 8,896 | 9.9 K to 8.9 K (-10.11 %) |
Nov 12 2008 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Manufacturing ... | Sell | S | 19.87 | 200 | 3,974 | 9,896 | 10.1 K to 9.9 K (-1.98 %) |
Nov 12 2008 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Manufacturing ... | Sell | S | 19.85 | 100 | 1,985 | 10,096 | 10.2 K to 10.1 K (-0.98 %) |
Apr 18 2008 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Manufacturing ... | Buy | J | 0.00 | 2,880 | 0 | 10,196 | 7.3 K to 10.2 K (+39.37 %) |
Mar 12 2008 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Manufacturing | Option Exercise | A | 7.00 | 40,000 | 280,000 | 40,000 | |
Jul 02 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corporate Affa ... | Option Exercise | M | 2.74 | 1,445 | 3,959 | 0 | |
Jul 02 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corporate Affa ... | Option Exercise | M | 2.74 | 1,446 | 3,962 | 1,445 | |
Jul 02 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corporate Affa ... | Sell | S | 9.93 | 1,250 | 12,413 | 7,316 | 8.6 K to 7.3 K (-14.59 %) |
Jul 02 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corporate Affa ... | Buy | M | 2.74 | 1,445 | 3,959 | 8,566 | 7.1 K to 8.6 K (+20.29 %) |
Jul 02 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corporate Affa ... | Sell | S | 9.69 | 1,446 | 14,012 | 7,121 | 8.6 K to 7.1 K (-16.88 %) |
Jul 02 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corporate Affa ... | Buy | M | 2.74 | 1,446 | 3,962 | 8,567 | 7.1 K to 8.6 K (+20.31 %) |
Jun 28 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corporate Affa ... | Option Exercise | M | 2.74 | 1,445 | 3,959 | 2,891 | |
Jun 28 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corporate Affa ... | Option Exercise | M | 2.74 | 1,445 | 3,959 | 4,336 | |
Jun 28 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corporate Affa ... | Sell | S | 9.58 | 1,445 | 13,843 | 7,121 | 8.6 K to 7.1 K (-16.87 %) |
Jun 28 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corporate Affa ... | Buy | M | 2.74 | 1,445 | 3,959 | 8,566 | 7.1 K to 8.6 K (+20.29 %) |
Jun 28 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corporate Affa ... | Sell | S | 9.36 | 1,445 | 13,525 | 7,121 | 8.6 K to 7.1 K (-16.87 %) |
Jun 28 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corporate Affa ... | Buy | M | 2.74 | 1,445 | 3,959 | 8,566 | 7.1 K to 8.6 K (+20.29 %) |
Jun 26 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corporate Affa ... | Option Exercise | M | 2.74 | 1,451 | 3,976 | 5,781 | |
Jun 26 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corporate Affa ... | Option Exercise | M | 2.74 | 1,447 | 3,965 | 7,232 | |
Jun 26 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corporate Affa ... | Sell | S | 9.16 | 1,451 | 13,291 | 7,121 | 8.6 K to 7.1 K (-16.93 %) |
Jun 26 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corporate Affa ... | Buy | M | 2.74 | 1,451 | 3,976 | 8,572 | 7.1 K to 8.6 K (+20.38 %) |
Jun 26 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corporate Affa ... | Sell | S | 8.90 | 1,300 | 11,570 | 7,121 | 8.4 K to 7.1 K (-15.44 %) |
Jun 26 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corporate Affa ... | Buy | M | 2.74 | 1,447 | 3,965 | 8,421 | 7 K to 8.4 K (+20.75 %) |
Jun 22 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corporate Affa ... | Option Exercise | M | 2.74 | 1,447 | 3,965 | 8,679 | |
Jun 22 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corporate Affa ... | Option Exercise | M | 2.74 | 1,447 | 3,965 | 10,126 | |
Jun 22 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corporate Affa ... | Sell | S | 9.00 | 1,316 | 11,844 | 6,974 | 8.3 K to 7 K (-15.87 %) |
Jun 22 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corporate Affa ... | Buy | M | 2.74 | 1,447 | 3,965 | 8,290 | 6.8 K to 8.3 K (+21.15 %) |
Jun 22 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corporate Affa ... | Sell | S | 9.37 | 1,336 | 12,518 | 6,843 | 8.2 K to 6.8 K (-16.33 %) |
Jun 22 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corporate Affa ... | Buy | M | 2.74 | 1,447 | 3,965 | 8,179 | 6.7 K to 8.2 K (+21.49 %) |
Jun 20 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corporate Affa ... | Option Exercise | M | 2.74 | 1,447 | 3,965 | 11,573 | |
Jun 20 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corporate Affa ... | Option Exercise | M | 2.74 | 1,447 | 3,965 | 13,020 | |
Jun 20 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corporate Affa ... | Sell | S | 9.83 | 1,405 | 13,811 | 6,732 | 8.1 K to 6.7 K (-17.27 %) |
Jun 20 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corporate Affa ... | Buy | M | 2.74 | 1,447 | 3,965 | 8,137 | 6.7 K to 8.1 K (+21.63 %) |
Jun 20 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corporate Affa ... | Sell | S | 10.07 | 1,405 | 14,148 | 6,690 | 8.1 K to 6.7 K (-17.36 %) |
Jun 20 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corporate Affa ... | Buy | M | 2.74 | 1,447 | 3,965 | 8,095 | 6.6 K to 8.1 K (+21.77 %) |
Jun 18 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corporate Affa ... | Option Exercise | M | 2.74 | 1,447 | 3,965 | 14,467 | |
Jun 18 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corporate Affa ... | Option Exercise | M | 2.74 | 1,427 | 3,910 | 15,914 | |
Jun 18 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corporate Affa ... | Option Exercise | A | 8.43 | 13,000 | 109,590 | 13,000 | |
Jun 18 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corporate Affa ... | Sell | S | 9.39 | 1,405 | 13,193 | 6,648 | 8.1 K to 6.6 K (-17.45 %) |
Jun 18 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corporate Affa ... | Buy | M | 2.74 | 1,447 | 3,965 | 8,053 | 6.6 K to 8.1 K (+21.90 %) |
Jun 18 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corporate Affa ... | Sell | S | 8.55 | 1,427 | 12,201 | 6,606 | 8 K to 6.6 K (-17.76 %) |
Jun 18 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corporate Affa ... | Buy | M | 2.74 | 1,427 | 3,910 | 8,033 | 6.6 K to 8 K (+21.60 %) |
Jun 14 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corporate Affa ... | Option Exercise | M | 2.74 | 4,219 | 11,560 | 17,341 | |
Jun 14 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corporate Affa ... | Option Exercise | M | 2.74 | 1,736 | 4,757 | 21,560 | |
Jun 14 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corporate Affa ... | Sell | S | 8.51 | 3,124 | 26,585 | 6,606 | 9.7 K to 6.6 K (-32.11 %) |
Jun 14 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corporate Affa ... | Buy | M | 2.74 | 4,219 | 11,560 | 9,730 | 5.5 K to 9.7 K (+76.56 %) |
Jun 14 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corporate Affa ... | Sell | S | 8.73 | 1,545 | 13,488 | 5,511 | 7.1 K to 5.5 K (-21.90 %) |
Jun 14 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corporate Affa ... | Buy | M | 2.74 | 1,736 | 4,757 | 7,056 | 5.3 K to 7.1 K (+32.63 %) |
Jun 12 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corporate Affa ... | Option Exercise | M | 2.74 | 1,930 | 5,288 | 23,296 | |
Jun 12 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corporate Affa ... | Option Exercise | M | 2.74 | 1,930 | 5,288 | 25,226 | |
Jun 12 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corporate Affa ... | Sell | S | 8.77 | 1,545 | 13,550 | 5,320 | 6.9 K to 5.3 K (-22.51 %) |
Jun 12 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corporate Affa ... | Buy | M | 2.74 | 1,930 | 5,288 | 6,865 | 4.9 K to 6.9 K (+39.11 %) |
Jun 12 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corporate Affa ... | Sell | S | 8.46 | 1,545 | 13,071 | 4,395 | 5.9 K to 4.4 K (-26.01 %) |
Jun 12 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corporate Affa ... | Buy | M | 2.74 | 1,930 | 5,288 | 6,480 | 4.6 K to 6.5 K (+42.42 %) |
Jun 08 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corporate Affa ... | Option Exercise | M | 2.74 | 1,911 | 5,236 | 27,156 | |
Jun 08 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corporate Affa ... | Option Exercise | M | 2.74 | 2,083 | 5,707 | 29,067 | |
Jun 08 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corporate Affa ... | Sell | S | 8.76 | 1,529 | 13,394 | 4,550 | 6.1 K to 4.6 K (-25.15 %) |
Jun 08 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corporate Affa ... | Buy | M | 2.47 | 1,911 | 4,720 | 6,079 | 4.2 K to 6.1 K (+45.85 %) |
Jun 08 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corporate Affa ... | Sell | S | 9.10 | 1,529 | 13,914 | 4,168 | 5.7 K to 4.2 K (-26.84 %) |
Jun 08 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corporate Affa ... | Buy | M | 2.47 | 2,083 | 5,145 | 5,697 | 3.6 K to 5.7 K (+57.64 %) |
Jun 06 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corp Affairs | Option Exercise | M | 2.74 | 1,959 | 5,368 | 31,150 | |
Jun 06 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corp Affairs | Option Exercise | M | 2.74 | 1,959 | 5,368 | 33,109 | |
Jun 06 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corp Affairs | Sell | S | 9.41 | 1,438 | 13,532 | 3,614 | 5.1 K to 3.6 K (-28.46 %) |
Jun 06 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corp Affairs | Buy | M | 2.74 | 1,959 | 5,368 | 5,052 | 3.1 K to 5.1 K (+63.34 %) |
Jun 06 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corp Affairs | Sell | S | 9.81 | 1,438 | 14,107 | 3,093 | 4.5 K to 3.1 K (-31.74 %) |
Jun 06 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corp Affairs | Buy | M | 2.74 | 1,959 | 5,368 | 4,531 | 2.6 K to 4.5 K (+76.17 %) |
Jun 04 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corp Affairs | Option Exercise | M | 2.74 | 1,959 | 5,368 | 35,068 | |
Jun 04 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corp Affairs | Option Exercise | M | 2.74 | 1,959 | 5,368 | 37,027 | |
Jun 04 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corp Affairs | Sell | S | 10.04 | 1,438 | 14,438 | 2,572 | 4 K to 2.6 K (-35.86 %) |
Jun 04 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corp Affairs | Buy | M | 2.74 | 1,959 | 5,368 | 4,010 | 2.1 K to 4 K (+95.51 %) |
Jun 04 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corp Affairs | Sell | S | 10.15 | 1,438 | 14,596 | 2,051 | 3.5 K to 2.1 K (-41.22 %) |
Jun 04 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corp Affairs | Buy | M | 2.74 | 1,959 | 5,368 | 3,489 | 1.5 K to 3.5 K (+128.04 %) |
May 31 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corp Affairs | Option Exercise | M | 2.74 | 1,798 | 4,927 | 38,986 | |
May 31 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corp Affairs | Option Exercise | M | 2.74 | 2,372 | 6,499 | 40,784 | |
May 31 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corp Affairs | Sell | S | 10.16 | 1,320 | 13,411 | 1,530 | 2.9 K to 1.5 K (-46.32 %) |
May 31 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corp Affairs | Buy | M | 2.74 | 1,798 | 4,927 | 2,850 | 1.1 K to 2.9 K (+170.91 %) |
May 31 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corp Affairs | Sell | S | 10.72 | 1,320 | 14,150 | 1,052 | 2.4 K to 1.1 K (-55.65 %) |
May 31 2007 | EBS | Emergent BioSoluti ... | Keese Kyle | SVP, Corp Affairs | Buy | M | 2.74 | 2,372 | 6,499 | 2,372 | 0 to 2.4 K |
Page: 1